HELSINKI, Finland – November 24, 2023
Institut de Cancérologie de Lorraine (ICL) in Nancy (France) has been a MVision AI customer since the installation of Contour+ in January 2023. This year, the values of using Guideline-Based AI Segmentation in daily practice have been prominently featured in several French media outlets [1], thanks to the efforts of Dr. Jean Christophe Faivre, head of the radiation oncology department. In fact, France Bleu even compared the results of using Contour+ to a small revolution in radiotherapy treatment.
Clinicians have particularly emphasized the accuracy and time-saving benefits, which allow for more time to be allocated to patient care and target identification.
“The accuracy of organ-at-risk (OAR) contouring can significantly influence cancer treatment planning. Contour+, powered by AI, not only assists us in contouring these critical organs to protect them but also enables us to achieve much greater precision while saving time“, says Dr. Jean Christophe Faivre.
Today we manually outline ten to fifteen patients a day, with Contour+, the medical team can easily handle twenty to thirty. This allows us to create much finer and more personalized irradiation plans, ultimately benefiting the patients. The tool is also invaluable in mitigating the current shortage of healthcare professionals in French hospitals. Our team eagerly anticipates future developments with AI“.
ICL is upfront in using artificial intelligence for cancer patients care and we are proud to reach the next steps in the near future by providing MVision AI Guide & Verify web workspaces designed to support clinical teams in the adoption of responsible AI with contour comparison and standardization towards guidelines.
About Institut de Cancérologie de Lorraine – Alexis Vautrin
The Institute of Cancer Research, along with its affiliation to Unicancer through Alexis Vautrin, plays a vital role as the central hub for cancer control in the Lorraine region. ICL is dedicated to delivering both standard and highly specialized care to cancer patients. Established in 1924, the Institut de Cancerologie de Lorraine holds a prominent position as a reference institution, providing tailored care pathways for patients and ensuring optimal care through the latest technological advancements. In 2022, the ICL achieved certification by the High Health Authority (HAS) at the “High Quality of Care” level, underscoring its commitment to excellence.
Institut de Cancérologie de Lorraine – ICL Linkedin page
About MVision AI
MVision AI is your dedicated partner in healthcare innovation. Our team comprises experienced Radiation Oncologists, Radiation Therapists, Medical Physicists and Clinical Scientists with a strong commitment to transforming the landscape of cancer care through the utilization of state-of-the-art AI technology. Our GBS™ Guideline-Based segmentation solution, powered by AI, is designed to streamline treatment planning, enabling clinicians to focus on personalized treatment plans that consider each patient’s distinct anatomy and medical history. This approach can potentially yield enhanced treatment outcomes, reduced side effects, and shorter treatment durations. The GBS™ suite encompasses three groundbreaking products for radiation therapy: the extensively updated Contour+ [2], and the recently launched Guide and Verify [3].
References
[1] Francebleu.fr – L’intelligence artificielle au service des patients atteints de cancer à Nancy
Europe1.fr – Nancy : l’intelligence artificielle au service des patients atteints de cancers
